LumaCyte's mission is to provide researchers with a transformational diagnostic tool that accelerates medical and pharmaceutical discoveries through novel cell analysis and sorting. Our vision is to empower researchers to ask questions and seek answers without the bias of antibody-based diagnostics. Our cell analysis and sorting philosophy is based on the enormous potential of measuring the native response of a cell to its environment and the ability to detect subtle changes in cell morphology, biochemistry, and biophysical properties.
Our values, passion, and drive are based upon the desire to help humankind better understand disease to accelerate therapies and cures.
LumaCyte is an advanced research and bioanalytics instrumentation company headquartered in Charlottesville, VA. LumaCyte produces label-free, single cell analysis and sorting instrumentation where the use of antibody or genetic labelling is not required for cellular analysis. This revolutionary technology utilizes Laser Force Cytology™ (LFC™) to measure optical and fluidic forces within a microfluidic channel to identify and measure the intrinsic cellular properties of each cell. The multivariate nature of the data has enabled a host of Big Data strategies and cloud computing capabilities that drive advanced analytics, allowing a deeper understanding of cell based biological systems. Applications of LumaCyte’s label-free platform technology include viral infectivity for vaccine development and manufacturing, cancer biology R&D, CAR-T Immunotherapy, cell and gene therapy, iPSCs, infectious disease, and pre-clinical drug discovery, in addition to multiple applications across the biomanufacturing sector for quality control and process optimization.
Since launching its flagship label-free single cell analysis instrument, Radiance in late 2017, LumaCyte has been working with customers in the vaccine manufacturing space for rapid automated viral infectivity measurements. The demand and interest from the biopharma and life science community has been overwhelming. LumaCyte is thrilled to be considered an innovator in the single cell analysis market and is honored to be working with forward thinking life science companies to transform research and development and biomanufacturing processes.